These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17455694)

  • 1. [Mucosal vaccine: the powerful weapon for the host defense].
    Takahashi I
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():632-6. PubMed ID: 17455694
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mucosal immunity and vaccine development].
    Anjuère F; Czerkinsky C
    Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
    Boyaka PN
    J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New horizon of mucosal immunity and vaccines.
    Takahashi I; Nochi T; Yuki Y; Kiyono H
    Curr Opin Immunol; 2009 Jun; 21(3):352-8. PubMed ID: 19493665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards an AIDS mucosal vaccine: an overview.
    Yuki Y; Nochi T; Kiyono H
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S35-44. PubMed ID: 17652028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of oral vaccines].
    Matsubara A; Shimizu Y; Karamatsu K; Yasutomi Y
    Nihon Rinsho; 2008 Oct; 66(10):1873-8. PubMed ID: 18939484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vivo analysis of IgA- and IgG-mediated mucosal defense against bacterial pathogens.
    Steinmetz I
    Behring Inst Mitt; 1997 Feb; (98):53-5. PubMed ID: 9382769
    [No Abstract]   [Full Text] [Related]  

  • 8. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens.
    McGhee JR; Mestecky J
    Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development.
    Kiyono H; Bienenstock J; McGhee JR; Ernst PB
    Reg Immunol; 1992; 4(2):54-62. PubMed ID: 1503889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Properties of mucosal antibodies].
    Quan C; Decroix N; Bouvet JP
    J Soc Biol; 2001; 195(2):119-24. PubMed ID: 11723823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunity: overcoming the barrier for induction of proximal responses.
    McKenzie BS; Brady JL; Lew AM
    Immunol Res; 2004; 30(1):35-71. PubMed ID: 15258310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of a mutant TNF-alpha as a vaccine adjuvant for the induction of mucosal immune responses.
    Kayamuro H; Abe Y; Yoshioka Y; Katayama K; Nomura T; Yoshida T; Yamashita K; Yoshikawa T; Kawai Y; Mayumi T; Hiroi T; Itoh N; Nagano K; Kamada H; Tsunoda S; Tsutsumi Y
    Biomaterials; 2009 Oct; 30(29):5869-76. PubMed ID: 19646748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunity: induction, dissemination, and effector functions.
    Brandtzaeg P
    Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal Vaccine Development Based on Liposome Technology.
    Bernasconi V; Norling K; Bally M; Höök F; Lycke NY
    J Immunol Res; 2016; 2016():5482087. PubMed ID: 28127567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new candidates as mucosal vaccine adjuvant in TNF family cytokines.
    Kayamuro H; Yoshioka Y; Abe Y; Katayama K; Arita S; Nomura T; Yoshikawa T; Itoh N; Kamada H; Tsunoda S; Tsutsumi Y
    Adv Exp Med Biol; 2011; 691():299-304. PubMed ID: 21153334
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current progress in the development of mucosal vaccines].
    Takeyama N; Yuki Y; Kiyono H
    Nihon Rinsho; 2011 Sep; 69(9):1555-60. PubMed ID: 21922752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
    Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
    Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccines on mucosal surfaces].
    Bout D; Mévélec MN; Velge-Roussel F; Dimier-Poisson I; Lebrun M
    Arch Pediatr; 2003 Jun; 10(6):565-70. PubMed ID: 12915029
    [No Abstract]   [Full Text] [Related]  

  • 20. [Host defense in respiratory infections].
    Kasahara K; Mikasa K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():97-101. PubMed ID: 17455599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.